Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, et al: Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 141:e139–e596. 2020. View Article : Google Scholar : PubMed/NCBI

Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al: Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 76:2982–3021. 2020. View Article : Google Scholar : PubMed/NCBI

Del Re DP, Amgalan D, Linkermann A, Liu Q and Kitsis RN: Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease. Physiol Rev. 99:1765–1817. 2019. View Article : Google Scholar : PubMed/NCBI

Reis AH: From Assessing Risk Factors to Understanding, Preventing, and Treating Cardiovascular Diseases: An urgent journey. Discov Med. 34:199–204. 2022.

Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al: Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI

Gao M, Yi J, Zhu J, Minikes AM, Monian P, Thompson CB and Jiang X: Role of Mitochondria in Ferroptosis. Mol Cell. 73:354–363.e3. 2019. View Article : Google Scholar :

Powell LW, Seckington RC and Deugnier Y: Haemochromatosis. Lancet. 388:706–716. 2016. View Article : Google Scholar : PubMed/NCBI

Park E and Chung SW: ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death Dis. 10:8222019. View Article : Google Scholar : PubMed/NCBI

Song Y, Wang B, Zhu X, Hu J, Sun J, Xuan J and Ge Z: Human umbilical cord blood-derived MSCs exosome attenuate myocardial injury by inhibiting ferroptosis in acute myocardial infarction mice. Cell Biol Toxicol. 37:51–64. 2021. View Article : Google Scholar

Li W, Li W, Leng Y, Xiong Y and Xia Z: Ferroptosis is involved in diabetes myocardial ischemia/reperfusion injury through endoplasmic reticulum stress. DNA Cell Biol. 39:210–225. 2020. View Article : Google Scholar

Gaschler MM and Stockwell BR: Lipid peroxidation in cell death. Biochem Biophys Res Commun. 482:419–425. 2017. View Article : Google Scholar : PubMed/NCBI

Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK, Kagan VE, et al: Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell. 171:273–285. 2017. View Article : Google Scholar : PubMed/NCBI

Stoyanovsky DA, Tyurina YY, Shrivastava I, Bahar I, Tyurin VA, Protchenko O, Jadhav S, Bolevich SB, Kozlov AV, Vladimirov YA, et al: Iron catalysis of lipid peroxidation in ferroptosis: Regulated enzymatic or random free radical reaction? Free Radic Biol Med. 133:153–161. 2019. View Article : Google Scholar :

Lin Z, Liu J, Kang R, Yang M and Tang D: Lipid Metabolism in Ferroptosis. Adv Biol (Weinh). 5:e21003962021. View Article : Google Scholar : PubMed/NCBI

Conrad M and Pratt DA: The chemical basis of ferroptosis. Nat Chem Biol. 15:1137–1147. 2019. View Article : Google Scholar : PubMed/NCBI

Naoe S, Tsugawa H, Takahashi M, Ikeda K and Arita M: Characterization of lipid profiles after dietary intake of polyunsaturated fatty acids using integrated untargeted and targeted lipidomics. Metabolites. 9:2412019. View Article : Google Scholar : PubMed/NCBI

Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB, et al: Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 13:81–90. 2017. View Article : Google Scholar

Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A, et al: ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 13:91–98. 2017. View Article : Google Scholar :

Li Y, Feng D, Wang Z, Zhao Y, Sun R, Tian D, Liu D, Zhang F, Ning S, Yao J and Tian X: Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion. Cell Death Differ. 26:2284–2299. 2019. View Article : Google Scholar : PubMed/NCBI

Orafaie A, Mousavian M, Orafai H and Sadeghian H: An overview of lipoxygenase inhibitors with approach of in vivo studies. Prostaglandins Other Lipid Mediat. 148:1064112020. View Article : Google Scholar : PubMed/NCBI

Smith LM, Aitken HM and Coote ML: The Fate of the Peroxyl Radical in Autoxidation: How does polymer degradation really occur? Acc Chem Res. 51:2006–2013. 2018. View Article : Google Scholar : PubMed/NCBI

Ilari S, Giancotti LA, Lauro F, Gliozzi M, Malafoglia V, Palma E, Tafani M, Russo MA, Tomino C, Fini M, et al: Natural antioxidant control of neuropathic pain-exploring the role of mitochondrial SIRT3 pathway. Antioxidants (Basel). 9:11032020. View Article : Google Scholar : PubMed/NCBI

Fan X, Li A, Yan Z, Geng X, Lian L, Lv H, Gao D and Zhang J: From iron metabolism to ferroptosis: Pathologic changes in coronary heart disease. Oxid Med Cell Longev. 2022:62918892022. View Article : Google Scholar : PubMed/NCBI

Hu H, Chen Y, Jing L, Zhai C and Shen L: The Link Between Ferroptosis and Cardiovascular Diseases: A novel target for treatment. Front Cardiovasc Med. 8:7109632021. View Article : Google Scholar : PubMed/NCBI

Chen Z, Yan Y, Qi C, Liu J, Li L and Wang J: The Role of Ferroptosis in Cardiovascular Disease and Its Therapeutic Significance. Front Cardiovasc Med. 8:7332292021. View Article : Google Scholar : PubMed/NCBI

Zhang Y, Xin L, Xiang M, Shang C, Wang Y, Wang Y, Cui X and Lu Y: The molecular mechanisms of ferroptosis and its role in cardiovascular disease. Biomed Pharmacother. 145:1124232022. View Article : Google Scholar

Yu Y, Jiang L, Wang H, Shen Z, Cheng Q, Zhang P, Wang J, Wu Q, Fang X, Duan L, et al: Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis. Blood. 136:726–739. 2020. View Article : Google Scholar : PubMed/NCBI

Mancias JD, Wang X, Gygi SP, Harper JW and Kimmelman AC: Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature. 509:105–109. 2014. View Article : Google Scholar : PubMed/NCBI

Fang X, Ardehali H, Min J and Wang F: The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol. 20:7–23. 2023. View Article : Google Scholar

Yuan H, Li X, Zhang X, Kang R and Tang D: CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation. Biochem Biophys Res Commun. 478:838–844. 2016. View Article : Google Scholar : PubMed/NCBI

Kim EH, Shin D, Lee J, Jung AR and Roh JL: CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer. Cancer Lett. 432:180–190. 2018. View Article : Google Scholar : PubMed/NCBI

Sies H: Glutathione and its role in cellular functions. Free Radic Biol Med. 27:916–921. 1999. View Article : Google Scholar : PubMed/NCBI

Wu G, Fang YZ, Yang S, Lupton JR and Turner ND: Glutathione Metabolism and Its Implications for Health. J Nutr. 134:489–492. 2004. View Article : Google Scholar : PubMed/NCBI

Pompella A, Visvikis A, Paolicchi A, Tata VD and Casini AF: The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol. 66:1499–1503. 2003. View Article : Google Scholar : PubMed/NCBI

Paul BD, Sbodio JI and Snyder SH: Cysteine Metabolism in Neuronal Redox Homeostasis. Trends Pharmacol Sci. 39:513–524. 2018. View Article : Google Scholar : PubMed/NCBI

Ursini F and Maiorino M: Lipid peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic Biol Med. 152:175–185. 2020. View Article : Google Scholar : PubMed/NCBI

Desideri E, Ciccarone F and Ciriolo MR: Targeting glutathione metabolism: Partner in crime in anticancer therapy. Nutrients. 11:19262019. View Article : Google Scholar : PubMed/NCBI

Wang Y, Zhao Y, Wang H, Zhang C, Wang M, Yang Y, Xu X and Hu Z: Histone demethylase KDM3B protects against ferroptosis by upregulating SLC7A11. FEBS Open Bio. 10:637–643. 2020. View Article : Google Scholar : PubMed/NCBI

Liu J, Zhang C, Hu W and Feng Z: Tumor suppressor p53 and metabolism. J Mol Cell Biol. 11:284–292. 2019. View Article : Google Scholar :

Kastenhuber ER and Lowe SW: Putting p53 in Context. Cell. 170:1062–1078. 2017. View Article : Google Scholar : PubMed/NCBI

Zille M, Karuppagounder SS, Chen Y, Gough PJ, Bertin J, Finger J, Milner TA, Jonas EA and Ratan RR: Neuronal death after hemorrhagic stroke in vitro and in vivo shares features of ferroptosis and necroptosis. Stroke. 48:1033–1043. 2017. View Article : Google Scholar : PubMed/NCBI

Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R and Tang D: Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 63:173–184. 2016. View Article : Google Scholar

Dodson M, Castro-Portuguez R and Zhang DD: NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 23:1011072019. View Article : Google Scholar : PubMed/NCBI

Kang R, Kroemer G and Tang D: The tumor suppressor protein p53 and the ferroptosis network. Free Radic Biol Med. 133:162–168. 2019. View Article : Google Scholar

Lipper CH, Stofleth JT, Bai F, Sohn YS, Roy S, Mittler R, Nechushtai R, Onuchic JN and Jennings PA: Redox-dependent gating of VDAC by mitoNEET. Proc Natl Acad Sci USA. 116:19924–19929. 2019. View Article : Google Scholar : PubMed/NCBI

Rostovtseva TK, Tan W and Colombini M: On the Role of VDAC in Apoptosis: Fact and Fiction. J Bioenerg Biomembr. 37:129–142. 2005. View Article : Google Scholar : PubMed/NCBI

Fang D and Maldonado EN: VDAC regulation: A mitochondrial target to stop cell proliferation. Adv Cancer Res. 138:41–69. 2018. View Article : Google Scholar : PubMed/NCBI

Mazure NM: VDAC in cancer. Biochim Biophys Acta Bioenerg. 1858:665–673. 2017. View Article : Google Scholar : PubMed/NCBI

Lemasters JJ: Evolution of Voltage-Dependent Anion Channel Function: From molecular sieve to governator to actuator of ferroptosis. Front Oncol. 7:3032017. View Article : Google Scholar

Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM, Boniface JJ, et al: RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature. 447:865–868. 2007. View Article : Google Scholar

DeHart DN, Fang D, Heslop K, Li L, Lemasters JJ and Maldonado EN: Opening of voltage dependent anion channels promotes reactive oxygen species generation, mitochondrial dysfunction and cell death in cancer cells. Biochem Pharmacol. 148:155–162. 2018. View Article : Google Scholar : PubMed/NCBI

Iurlaro R and Muñoz-Pinedo C: Cell death induced by endoplasmic reticulum stress. FEBS J. 283:2640–2652. 2016. View Article : Google Scholar

Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS and Stockwell BR: Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife. 3:e025232014. View Article : Google Scholar : PubMed/NCBI

Chen Y, Mi Y, Zhang X, Ma Q, Song Y, Zhang L, Wang D, Xing J, Hou B, Li H, et al: Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells. J Exp Clin Cancer Res. 38:4022019. View Article : Google Scholar : PubMed/NCBI

Luo Y, Guo Q, Zhang L, Zhuan Q, Meng L, Fu X and Hou Y: Dihydroartemisinin exposure impairs porcine ovarian granulosa cells by activating PERK-eIF2α-ATF4 through endoplasmic reticulum stress. Toxicol Appl Pharmacol. 403:1151592020. View Article : Google Scholar

Rozpedek W, Pytel D, Mucha B, Leszczynska H, Diehl JA and Majsterek I: The Role of the PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress. Curr Mol Med. 16:533–544. 2016. View Article : Google Scholar

Yan L, Luo H, Li X and Li Y: d-Pinitol protects against endoplasmic reticulum stress and apoptosis in hepatic ischemia-reperfusion injury via modulation of AFT4-CHOP/GRP78 and caspase-3 signaling pathways. Int J Immunopathol Pharmacol. 35:1–15. 2021. View Article : Google Scholar

Chen Y, Mi Y and Zhang X: The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. J Cell Physiol. 575:688–692. 2019.

Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, Goya Grocin A, Xavier da Silva TN, Panzilius E, Scheel CH, et al: FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 575:693–698. 2019. View Article : Google Scholar : PubMed/NCBI

Shimada K, Skouta R, Kaplan A, Yang WS, Hayano M, Dixon SJ, Brown LM, Valenzuela CA, Wolpaw AJ and Stockwell BR: Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat Chem Biol. 12:497–503. 2016. View Article : Google Scholar : PubMed/NCBI

Miriyala S, Thippakorn C, Chaiswing L, Xu Y, Noel T, Tovmasyan A, Batinic-Haberle I, Vander Kooi CW, Chi W, Latif AA, et al: Novel role of 4-hydroxy-2-nonenal in AIFm2-mediated mitochondrial stress signaling. Free Radic Biol Med. 91:68–80. 2016. View Article : Google Scholar :

Martinet W, Coornaert I, Puylaert P and De Meyer GRY: Macrophage death as a pharmacological target in atherosclerosis. Front Pharmacol. 10:3062019. View Article : Google Scholar : PubMed/NCBI

Xiao L, Luo G, Guo X, Jiang C, Zeng H, Zhou F, Li Y, Yu J and Yao P: Macrophage iron retention aggravates atherosclerosis: Evidence for the role of autocrine formation of hepcidin in plaque macrophages. Biochim Biophys Acta Mol Cell Biol Lipids. 1865:1585312020. View Article : Google Scholar

Kiechl S, Willeit J, Egger G, Poewe W and Oberhollenzer F: Body Iron Stores and the Risk of Carotid Atherosclerosis: Prospective results from the Bruneck study. Circulation. 96:3300–3307. 1997. View Article : Google Scholar : PubMed/NCBI

Hou JW: Iron-load exacerbates the severity of atherosclerosis via inducing inflammation and enhancing the glycolysis in macrophages. Nutrition. 38:329–334. 2002.

Luo EF, Li HX, Qin YH, Qiao Y, Yan GL, Yao YY, Li LQ, Hou JT, Tang CC and Wang D: Role of ferroptosis in the process of diabetes-induced endothelial dysfunction. World J Diabetes. 12:124–137. 2021. View Article : Google Scholar : PubMed/NCBI

Park TJ, Park JH, Lee GS, Lee JY, Shin JH, Kim MW, Kim YS, Kim JY, Oh KJ, Han BS, et al: Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes. Cell Death Dis. 10:8352019. View Article : Google Scholar : PubMed/NCBI

Baba Y, Higa JK, Shimada BK, Horiuchi KM, Suhara T, Kobayashi M, Woo JD, Aoyagi H, Marh KS, Kitaoka H, et al: Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes. Am J Physiol Heart Circ Physiol. 314:H659–H668. 2018. View Article : Google Scholar :

Zhang T, Zhang Y, Cui M, Jin L, Wang Y, Lv F, Liu Y, Zheng W, Shang H, Zhang J, et al: CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. Nat Med. 22:175–182. 2016. View Article : Google Scholar : PubMed/NCBI

Farmer EE and Mueller MJ: ROS-Mediated Lipid Peroxidation and RES-Activated Signaling. Annu Rev Plant Biol. 64:429–450. 2013. View Article : Google Scholar : PubMed/NCBI

Scindia Y PhD, Leeds J MD and Swaminathan S MD: Iron homeostasis in healthy kidney and its role in acute kidney injury. Semin Nephrol. 39:76–84. 2019. View Article : Google Scholar

Gao M, Monian P, Quadri N, Ramasamy R and Jiang X: Glutaminolysis and transferrin regulate ferroptosis. Mol Cell. 59:298–308. 2015. View Article : Google Scholar : PubMed/NCBI

Fang X, Wang H, Han D, Xie E, Yang X, Wei J, Gu S, Gao F, Zhu N, Yin X, et al: Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci USA. 116:2672–2680. 2019. View Article : Google Scholar : PubMed/NCBI

Tang LJ, Luo XJ, Tu H, Chen H, Xiong XM, Li NS and Peng J: Ferroptosis occurs in phase of reperfusion but not ischemia in rat heart following ischemia or ischemia/reperfusion. Naunyn Schmiedebergs Arch Pharmacol. 394:401–410. 2021. View Article : Google Scholar

Hess ML and Manson NH: Molecular oxygen: Friend and foe*The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. J Mol Cell Cardiol. 37:969–985. 1984. View Article : Google Scholar

Ghosh AP, Klocke BJ, Ballestas ME and Roth KA: CHOP Potentially Co-Operates with FOXO3a in Neuronal Cells to Regulate PUMA and BIM Expression in Response to ER Stress. PLoS One. 7:e395862012. View Article : Google Scholar : PubMed/NCBI

Lee YS, Lee DH, Choudry HA, Bartlett DL and Lee YJ: Ferroptosis-Induced Endoplasmic Reticulum Stress: Cross-talk between Ferroptosis and Apoptosis. Mol Cancer Res. 16:1073–1076. 2018. View Article : Google Scholar : PubMed/NCBI

Sampilvanjil A, Karasawa T and Yamada N: Endoplasmic Reticulum Stress and oxidative stress in cell fate decision and human disease. Proc Natl Acad Sci USA. 160:303–318. 2020.

Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, et al: Classification of the cardiomyopathies: A position statement from the European Society Of Cardiology Working Group On Myocardial And Pericardial Diseases. Eur Heart J. 29:270–276. 2008. View Article : Google Scholar

Hashimoto H, Olson EN and Bassel-Duby R: Therapeutic approaches for cardiac regeneration and repair. Nat Rev Cardiol. 15:585–600. 2018. View Article : Google Scholar : PubMed/NCBI

Young RC, Ozols RF and Myers CE: The anthracycline antineoplastic drugs. N Engl J Med. 305:139–153. 1981. View Article : Google Scholar : PubMed/NCBI

Singal PK and Iliskovic N: Doxorubicin-induced cardiomyopathy. N Engl J Med. 339:900–905. 1998. View Article : Google Scholar : PubMed/NCBI

Tadokoro T, Ikeda M and Ide T: Mitochondrial outer membrane protein FUNDC2 promotes ferroptosis and contributes to doxorubicin-induced cardiomyopathy. Am J Physiol Heart Circ Physiol. 119:e21173961192022.

Sun X, Sun P, Zhen D, Xu X, Yang L, Fu D, Wei C, Niu X, Tian J and Li H: Melatonin alleviates doxorubicin-induced mitochondrial oxidative damage and ferroptosis in cardiomyocytes by regulating YAP expression. Toxicol Appl Pharmacol. 437:1159022022. View Article : Google Scholar : PubMed/NCBI

Wang Y, Yan S, Liu X, Deng F, Wang P, Yang L, Hu L, Huang K and He J: PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway. Cell Death Differ. 29:1982–1995. 2022. View Article : Google Scholar : PubMed/NCBI

Zhuang S, Ma Y, Zeng Y, Lu C, Yang F, Jiang N, Ge J, Ju H, Zhong C, Wang J, et al: METTL14 promotes doxorubicin-induced cardiomyocyte ferroptosis by regulating the KCNQ1OT1-miR-7-5p-TFRC axis. Cell Biol Toxicol. 39:1015–1035. 2023. View Article : Google Scholar

Wang B, Wang H, Zhang M, Ji R, Wei J, Xin Y and Jiang X: Radiation-induced myocardial fibrosis: Mechanisms underlying its pathogenesis and therapeutic strategies. J Cell Mol Med. 24:7717–7729. 2020. View Article : Google Scholar : PubMed/NCBI

Wang H, Wei J, Zheng Q, Meng L, Xin Y, Yin X and Jiang X: Radiation-induced heart disease: A review of classification, mechanism and prevention. Int J Biol Sci. 15:2128–2138. 2019. View Article : Google Scholar : PubMed/NCBI

Kuwahara Y, Oikawa T, Ochiai Y, Roudkenar MH and Fukumoto M, Shimura T, Ohtake Y, Ohkubo Y, Mori S, Uchiyama Y and Fukumoto M: Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy. Cell Death Dis. 2:e1772011. View Article : Google Scholar : PubMed/NCBI

Jelonek K, Walaszczyk A, Gabryś D, Pietrowska M, Kanthou C and Widłak P: Cardiac endothelial cells isolated from mouse heart-a novel model for radiobiology. Acta Biochim Pol. 58:397–404. 2011. View Article : Google Scholar

Taunk NK, Haffty BG, Kostis JB and Goyal S: Radiation-Induced Heart Disease: Pathologic Abnormalities and Putative Mechanisms. Front Oncol. 5:392015. View Article : Google Scholar : PubMed/NCBI

Klein D, Steens J, Wiesemann A, Schulz F, Kaschani F, Röck K, Yamaguchi M, Wirsdörfer F, Kaiser M, Fischer JW, et al: Mesenchymal stem cell therapy protects lungs from radiation-induced endothelial cell loss by restoring superoxide dismutase 1 expression. Antioxid Redox Signal. 26:563–582. 2017. View Article : Google Scholar :

Liao JK: Linking endothelial dysfunction with endothelial cell activation. Front Oncol. 123:540–541. 2013.

Van Der Meeren A, Squiban C, Gourmelon P, Lafont H and Gaugler MH: Differential regulation by IL-4 and IL-10 of radiation-induced IL-6 AND IL-8 production and ICAM-1 expression by human endothelial cells. Cytokine. 11:831–838. 1999. View Article : Google Scholar : PubMed/NCBI

Baselet B, Belmans N, Coninx E, Lowe D, Janssen A, Michaux A, Tabury K, Raj K, Quintens R, Benotmane MA, et al: Functional gene analysis reveals cell cycle changes and inflammation in endothelial cells irradiated with a single X-ray dose. Front Pharmacol. 8:2132017. View Article : Google Scholar : PubMed/NCBI

Mortezaee K, Goradel NH, Amini P, Shabeeb D, Musa AE, Najafi M and Farhood B: NADPH oxidase as a target for modulation of radiation response; Implications to carcinogenesis and radiotherapy. Curr Mol Pharmacol. 12:50–60. 2019. View Article : Google Scholar

Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin SH, Ajani JA, Xiao Q, Liao Z, Wang H and Gan B: The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 30:146–162. 2020. View Article : Google Scholar : PubMed/NCBI

Dixon SJ, Winter GE, Musavi LS, Lee ED, Snijder B, Rebsamen M, Superti-Furga G and Stockwell BR: Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem Biol. 10:1604–1609. 2015. View Article : Google Scholar : PubMed/NCBI

Philipp J, Le Gleut R, Toerne CV, Subedi P, Azimzadeh O, Atkinson MJ and Tapio S: Radiation response of human cardiac endothelial cells reveals a central role of the cGAS-STING pathway in the development of inflammation. Proteomes. 8:302020. View Article : Google Scholar : PubMed/NCBI

Heidenreich PA, Hancock SL, Lee BK, Mariscal CS and Schnittger I: Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol. 42:743–749. 2003. View Article : Google Scholar : PubMed/NCBI

Gong CW, Yuan MM, Qiu BQ, Wang LJ, Zou HX, Hu T, Lai SQ and Liu JC: Identification and Validation of Ferroptosis-Related Biomarkers in Septic Cardiomyopathy via Bioinformatics Analysis. Front Genet. 13:8275592022. View Article : Google Scholar : PubMed/NCBI

Kong C, Ni X, Wang Y, Zhang A, Zhang Y, Lin F, Li S, Lv Y, Zhu J, Yao X, et al: ICA69 aggravates ferroptosis causing septic cardiac dysfunction via STING trafficking. Cell Death Discov. 8:1872022. View Article : Google Scholar : PubMed/NCBI

Raman B, Bluemke DA, Lüscher TF and Neubauer S: Long COVID: Post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 43:1157–1172. 2022. View Article : Google Scholar : PubMed/NCBI

Xie Y, Xu E, Bowe B and Al-Aly Z: Long-term cardiovascular outcomes of COVID-19. Nat Med. 28:583–590. 2022. View Article : Google Scholar : PubMed/NCBI

Katsoularis I, Fonseca-Rodríguez O, Farrington P, Lindmark K and Fors Connolly AM: Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: A self-controlled case series and matched cohort study. Lancet. 398:599–607. 2021. View Article : Google Scholar : PubMed/NCBI

Xie Y, Bowe B, Maddukuri G and Al-Aly Z: Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: Cohort study. BMJ. 371:m46772020. View Article : Google Scholar : PubMed/NCBI

Merad M, Blish CA, Sallusto F and Iwasaki A: The immunology and immunopathology of COVID-19. Science. 375:1122–1127. 2022. View Article : Google Scholar : PubMed/NCBI

Wang Y, Huang J, Sun Y, Stubbs D, He J, Li W, Wang F, Liu Z, Ruzicka JA, Taylor EW, et al: SARS-CoV-2 suppresses mRNA expression of selenoproteins associated with ferroptosis, endoplasmic reticulum stress and DNA synthesis. Food Chem Toxicol. 153:1122862021. View Article : Google Scholar : PubMed/NCBI

Liu L, Du J, Yang S, Zheng B, Shen J, Huang J, Cao L, Huang S, Liu X, Guo L, et al: SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis. Redox Biol. 63:1027522023. View Article : Google Scholar : PubMed/NCBI

Bai T, Li M and Liu Y: Acyl-coenzyme a synthetase long-chain family member 4 is involved in viral replication organelle formation and facilitates virus replication via ferroptosis. Free Radic Biol Med. 63:194–209. 2020.

Han Y, Zhu J, Yang L, Nilsson-Payant BE, Hurtado R, Lacko LA, Sun X, Gade AR, Higgins CA, Sisso WJ, et al: SARS-CoV-2 infection induces ferroptosis of sinoatrial node pacemaker cells. Circ Res. 130:963–977. 2022. View Article : Google Scholar : PubMed/NCBI

Habib HM, Ibrahim S, Zaim A and Ibrahim WH: The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators. Biomed Pharmacother. 136:1112282021. View Article : Google Scholar : PubMed/NCBI

Jia G, DeMarco VG and Sowers JR: Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 12:144–153. 2016. View Article : Google Scholar :

Ritchie RH and Abel ED: Basic mechanisms of diabetic heart disease. Circ Res. 126:1501–1525. 2020. View Article : Google Scholar : PubMed/NCBI

Liu C, Sun W, Zhu T, Shi S, Zhang J, Wang J, Gao F, Ou Q, Jin C, Li J, et al: Glia maturation factor-β induces ferroptosis by impairing chaperone-mediated autophagic degradation of ACSL4 in early diabetic retinopathy. Redox Biol. 52:1022922022. View Article : Google Scholar

Chen L, Yin Z, Qin X, Zhu X, Chen X, Ding G, Sun D, Wu NN, Fei J, Bi Y, et al: CD74 ablation rescues type 2 diabetes mellitus-induced cardiac remodeling and contractile dysfunction through pyroptosis-evoked regulation of ferroptosis. Pharmacol Res. 176:1060862022. View Article : Google Scholar : PubMed/NCBI

Wei Z, Shaohuan Q, Pinfang K and Chao S: Curcumin attenuates ferroptosis-induced myocardial injury in diabetic cardiomyopathy through the Nrf2 pathway. Cardiovasc Ther. 2022:31597172022. View Article : Google Scholar : PubMed/NCBI

Kwon MY, Park E, Lee SJ and Chung SW: Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death. Oncotarget. 6:24393–24403. 2015. View Article : Google Scholar : PubMed/NCBI

Chang LC, Chiang SK, Chen SE, Yu YL, Chou RH and Chang WC: Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis. Cancer Lett. 416:124–137. 2018. View Article : Google Scholar

Wang X, Chen X, Zhou W, Men H, Bao T, Sun Y, Wang Q, Tan Y, Keller BB, Tong Q, et al: Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways. Acta Pharm Sin B. 12:708–722. 2022. View Article : Google Scholar : PubMed/NCBI

Zhang Z, Tang J, Song J, Xie M, Liu Y, Dong Z, Liu X, Li X, Zhang M, Chen Y, et al: Elabela alleviates ferroptosis, myocardial remodeling, fibrosis and heart dysfunction in hypertensive mice by modulating the IL-6/STAT3/GPX4 signaling. Free Radic Biol Med. 181:130–142. 2022. View Article : Google Scholar : PubMed/NCBI

Menon AV, Liu J, Tsai HP, Zeng L, Yang S, Asnani A and Kim J: Excess heme upregulates heme oxygenase 1 and promotes cardiac ferroptosis in mice with sickle cell disease. Blood. 139:936–941. 2022. View Article : Google Scholar :

Rozwadowska K, Raczak G, Sikorska K, Fijałkowski M, Kozłowski D and Daniłowicz-Szymanowicz L: Influence of hereditary haemochromatosis on left ventricular wall thickness: Does iron overload exacerbate cardiac hypertrophy? Folia Morphol (Warsz). 78:746–753. 2019. View Article : Google Scholar : PubMed/NCBI

Sukumaran A, Chang J, Han M, Mintri S, Khaw BA and Kim J: Iron overload exacerbates age-associated cardiac hypertrophy in a mouse model of hemochromatosis. Sci Rep. 7:57562017. View Article : Google Scholar : PubMed/NCBI

Fang X, Cai Z, Wang H, Han D, Cheng Q, Zhang P, Gao F, Yu Y, Song Z, Wu Q, et al: Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis. Circ Res. 127:486–501. 2020. View Article : Google Scholar : PubMed/NCBI

Zhang X, Zheng C, Gao Z, Chen H, Li K, Wang L, Zheng Y, Li C, Zhang H, Gong M, et al: SLC7A11/xCT prevents cardiac hypertrophy by inhibiting ferroptosis. Cardiovasc Drugs Ther. 36:437–447. 2022. View Article : Google Scholar

Papayannopoulos V: Methylation-dependent transcriptional repression of RUNX3 by KCNQ1OT1 regulates mouse cardiac microvascular endothelial cell viability and inflammatory response following myocardial infarction. Exp Mol Med. 53:401–426. 2019.

Shi P, Song C, Qi H, Ren J, Ren P, Wu J, Xie Y, Zhang M, Sun H and Cao Y: Up-regulation of IRF3 is required for docosahexaenoic acid suppressing ferroptosis of cardiac microvascular endothelial cells in cardiac hypertrophy rat. J Nutr Biochem. 104:1089722022. View Article : Google Scholar : PubMed/NCBI

Tang M, Huang Z, Luo X, Liu M, Wang L, Qi Z, Huang S, Zhong J, Chen JX, Li L, et al: Ferritinophagy activation and sideroflexin1-dependent mitochondria iron overload is involved in apelin-13-induced cardiomyocytes hypertrophy. Free Radical Biol Med. 134:445–457. 2019. View Article : Google Scholar

Chen X, Xu S, Zhao C and Liu B: Role of TLR4/NADPH oxidase 4 pathway in promoting cell death through autophagy and ferroptosis during heart failure. Biochem Biophys Res Commun. 516:37–43. 2019. View Article : Google Scholar : PubMed/NCBI

Bertoli SR, Marques VB, Rossi EM, Krause M, Carneiro MTWD, Simões MR and Dos Santos L: Chronic iron overload induces vascular dysfunction in resistance pulmonary arteries associated with right ventricular remodeling in rats. Toxicol Lett. 295:296–306. 2018. View Article : Google Scholar : PubMed/NCBI

Ciarambino T, Menna G, Sansone G and Giordano M: Cardiomyopathies: An overview. Int J Mol Sci. 22:77222021. View Article : Google Scholar : PubMed/NCBI

Reichart D, Magnussen C, Zeller T and Blankenberg S: Dilated cardiomyopathy: From epidemiologic to genetic phenotypes. J Intern Med. 286:362–372. 2019. View Article : Google Scholar : PubMed/NCBI

Eldemire R, Mestroni L and Taylor MRG: Genetics of Dilated Cardiomyopathy. Annu Rev Med. 75:417–426. 2024. View Article : Google Scholar :

Kadhi A, Mohammed F and Nemer G: The Genetic Pathways Underlying Immunotherapy in Dilated Cardiomyopathy. Front Cardiovasc Med. 8:6132952022. View Article : Google Scholar

Li D, Pi W, Sun Z, Liu X and Jiang J: Ferroptosis and its role in cardiomyopathy. Biomed Pharmacother. 153:1132792022. View Article : Google Scholar : PubMed/NCBI

Al-Adhami A, Avtaar Singh SS, De SD, Singh R, Panjrath G, Shah A, Dalzell JR, Schroder J and Al-Attar N: Primary graft dysfunction after heart transplantation-unravelling the enigma. Curr Probl Cardiol. 47:1009412022. View Article : Google Scholar

Gong CW, Yuan MM and Qiu BQ: Sterile inflammation in thoracic transplantation. Molecular Cell. 78:581–601. 2021. View Article : Google Scholar

Li W, Feng G, Gauthier JM, Lokshina I, Higashikubo R, Evans S, Liu X, Hassan A, Tanaka S, Cicka M, et al: Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation. J Clin Invest. 129:2293–2304. 2019. View Article : Google Scholar : PubMed/NCBI

Green DR: The coming decade of cell death research: Five Riddles. Cell. 177:1094–1107. 2019. View Article : Google Scholar : PubMed/NCBI

Shi L, Liu Y, Li M and Luo Z: Emerging roles of ferroptosis in the tumor immune landscape: from danger signals to anti-tumor immunity. FEBS J. 289:3655–3665. 2022. View Article : Google Scholar

Mallah SI, Atallah B, Moustafa F, Naguib M, El Hajj S, Bader F and Mehra MR: Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathy. Prog Cardiovasc Dis. 63:194–209. 2020. View Article : Google Scholar : PubMed/NCBI

Jin JL, Zhang HW, Cao YX, Liu HH, Hua Q, Li YF, Zhang Y, Wu NQ, Zhu CG, Xu RX, et al: Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: A prospective, observational cohort study. Cardiovasc Diabetol. 19:452020. View Article : Google Scholar : PubMed/NCBI

Li L, Wang H, Zhang J, Chen X, Zhang Z and Li Q: Effect of endothelial progenitor cell-derived extracellular vesicles on endothelial cell ferroptosis and atherosclerotic vascular endothelial injury. Cell Death Discov. 7:2352021. View Article : Google Scholar : PubMed/NCBI

McNerney ME, Lee KM, Zhou P, Molinero L, Mashayekhi M, Guzior D, Sattar H, Kuppireddi S, Wang CR, Kumar V and Alegre ML: Role of natural killer cell subsets in cardiac allograft rejection. Am J Transplant. 6:505–513. 2006. View Article : Google Scholar : PubMed/NCBI

Wang W, Green M, Choi JE, Gijón M, Kennedy PD, Johnson JK, Liao P, Lang X, Kryczek I, Sell A, et al: CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 569:270–274. 2019. View Article : Google Scholar : PubMed/NCBI

Kinsella A, Rao V, Fan CP, Manlhiot C, Stehlik J, Ross H and Alba AC: Post-transplant survival in adult congenital heart disease patients as compared to dilated and ischemic cardiomyopathy patients; an analysis of the thoracic ISHLT registry. Clin Transplant. 34:2020. View Article : Google Scholar : PubMed/NCBI

Aldouri MA, Wonke B, Hoffbrand AV, Flynn DM, Ward SE, Agnew JE and Hilson AJ: High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: Reversal by intensified chelation. Acta Haematol. 84:113–117. 1990. View Article : Google Scholar : PubMed/NCBI

Liu P and Olivieri N: Iron overload cardiomyopathies: New insights into an old disease. Cardiovasc Drug Ther. 8:101–110. 1994. View Article : Google Scholar

Engle MA, M Erlandson M and Smith CH: Late cardiac complications of chronic, severe, refractory anemia with hemochromatosis. Circulation. 30:698–705. 1964. View Article : Google Scholar : PubMed/NCBI

Quinlan GJ, Evans TW and Gutteridge JM: Iron and the redox status of the lungs. Free Radic Biol Med. 33:1306–1313. 2002. View Article : Google Scholar : PubMed/NCBI

Shvartsman M, Fibach E and Cabantchik ZI: Transferrin-iron routing to the cytosol and mitochondria as studied by live and real-time fluorescence. Biochem J. 429:185–193. 2010. View Article : Google Scholar : PubMed/NCBI

Oudit GY, Sun H, Trivieri MG, Koch SE, Dawood F, Ackerley C, Yazdanpanah M, Wilson GJ, Schwartz A, Liu PP and Backx PH: L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med. 9:1187–1194. 2003. View Article : Google Scholar : PubMed/NCBI

Tsushima RG, Wickenden AD, Bouchard RA, Oudit GY, Liu PP and Backx PH: Modulation of iron uptake in heart by L-Type Ca²⁺ channel modifiers. Circ Res. 84:1302–1309. 1999. View Article : Google Scholar : PubMed/NCBI

Das SK, Patel VB, Basu R, Wang W, DesAulniers J, Kassiri Z and Oudit GY: Females are protected from iron-overload cardiomyopathy independent of iron metabolism: Key role of oxidative stress. J Am Heart Assoc. 6:e0034562017. View Article : Google Scholar : PubMed/NCBI

Brewer C, Otto-Duessel M, Wood RI and Wood JC: Sex differences and steroid modulation of cardiac iron in a mouse model of iron overload. Transl Res. 163:151–159. 2014. View Article : Google Scholar :

Zhang H, Zhabyeyev P, Wang S and Oudit GY: Role of iron metabolism in heart failure: From iron deficiency to iron overload. Biochim Biophys Acta Mol Basis Dis. 1865:1925–1937. 2019. View Article : Google Scholar : PubMed/NCBI

Zhao X, Si L, Bian J, Pan C, Guo W, Qin P, Zhu W, Xia Y, Zhang Q and Wei K: Adipose tissue macrophage-derived exosomes induce ferroptosis via glutathione synthesis inhibition by targeting SLC7A11 in obesity-induced cardiac injury. Free Radic Biol Med. 182:232–245. 2022. View Article : Google Scholar : PubMed/NCBI

Nguyen NT, Nguyen TT, Da Ly D, Xia JB, Qi XF, Lee IK, Cha SK and Park KS: Oxidative stress by Ca²⁺ overload is critical for phosphate-induced vascular calcification. Am J Physiol Heart Circ Physiol. 319:H1302–H1312. 2020. View Article : Google Scholar

Akahori H, Tsujino T, Naito Y, Matsumoto M, Lee-Kawabata M, Ohyanagi M, Mitsuno M, Miyamoto Y, Daimon T, Hao H, et al: Intraleaflet haemorrhage is associated with rapid progression of degenerative aortic valve stenosis. Eur Heart J. 32:888–896. 2011. View Article : Google Scholar : PubMed/NCBI

Laguna-Fernandez A, Carracedo M, Jeanson G, Nagy E, Eriksson P, Caligiuri G, Franco-Cereceda A and Bäck M: Iron alters valvular interstitial cell function and is associated with calcification in aortic stenosis. Eur Heart J. 37:3532–3535. 2016. View Article : Google Scholar : PubMed/NCBI

Morvan M, Arangalage D, Franck G, Perez F, Cattan-Levy L, Codogno I, Jacob-Lenet MP, Deschildre C, Choqueux C, Even G, et al: Relationship of iron deposition to calcium deposition in human aortic valve leaflets. J Am Coll Cardiol. 73:1043–1054. 2019. View Article : Google Scholar : PubMed/NCBI

Xu Y, Lin H, Wang H, Pang J and Zhou Y: Fraxetin attenuates ferroptosis in myocardial infarction via AKT/Nrf2/HO-1 signaling. Am J Transl Res. 13:10315–10327. 2021.PubMed/NCBI

Liberman M, Bassi E, Martinatti MK, Lario FC, Wosniak J Jr, Pomerantzeff PM and Laurindo FR: Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol. 28:463–470. 2008. View Article : Google Scholar

Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, et al: 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: A cohort study. Lancet. 386:154–156. 2015. View Article : Google Scholar : PubMed/NCBI

Dai C, Kong B, Qin T, Xiao Z, Fang J, Gong Y, Zhu J, Liu Q, Fu H, Meng H, et al: Inhibition of ferroptosis reduces susceptibility to frequent excessive alcohol consumption-induced atrial fibrillation. Toxicology. 465:1530552022. View Article : Google Scholar

Rose RA, Sellan M, Simpson JA, Izaddoustdar F, Cifelli C, Panama BK, Davis M, Zhao D, Markhani M, Murphy GG, et al: Iron overload decreases CaV1.3-dependent L-type Ca²⁺ currents leading to bradycardia, altered electrical conduction, and atrial fibrillation. Circ Arrhythm Electrophysiol. 4:733–742. 2011. View Article : Google Scholar : PubMed/NCBI

Fang J, Kong B, Shuai W, Xiao Z, Dai C, Qin T, Gong Y, Zhu J, Liu Q and Huang H: Ferroportin-mediated ferroptosis involved in new-onset atrial fibrillation with LPS-induced endotoxemia. Front Pharmacol. 913:1746222021.

Liu D, Yang M, Yao Y, He S, Wang Y, Cao Z, Chen H, Fu Y, Liu H and Zhao Q: Cardiac fibroblasts promote ferroptosis in atrial fibrillation by secreting Exo-miR-23a-3p Targeting SLC7A11. Oxid Med Cell Longev. 2022:39614952022.PubMed/NCBI

Russo V, Rago A, Pannone B, Di Meo F, Papa AA, Mayer MC, Spasiano A, Russo MG, Golino P, Calabrò R and Nigro G: Early electrocardiographic evaluation of atrial fibrillation risk in beta-thalassemia major patients. Int J Hematol. 93:446–451. 2011. View Article : Google Scholar : PubMed/NCBI

Lee AS, Jung YJ, Thanh TN, Lee S, Kim W, Kang KP and Park SK: Paricalcitol attenuates lipopolysaccharide-induced myocardial inflammation by regulating the NF-κB signaling pathway. Int J Mol Med. 37:1023–1029. 2016. View Article : Google Scholar : PubMed/NCBI

Li N, Wang W, Zhou H, Wu Q, Duan M, Liu C, Wu H, Deng W, Shen D and Tang Q: Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury. Free Radic Biol Med. 160:303–318. 2020. View Article : Google Scholar : PubMed/NCBI

Calne DB and Calne JS: Normality and Disease. Can J Neurol Sci. 15:3–4. 1988. View Article : Google Scholar : PubMed/NCBI

Kung YA, Chiang HJ and Li ML: Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID-19): Autopsy reveals a ferroptosis signature. Clin Transplant. 130:113–117. 1990.

Wang YD, Liu ZJ, Ren J and Xiang MX: Pharmacological Therapy of Abdominal Aortic Aneurysm: An Update. Curr Vasc Pharmacol. 16:114–124. 2018. View Article : Google Scholar

Wang K, Song Y, Li H, Song J and Wang S: Identification of differentially expressed ferroptosis-related genes in abdominal aortic aneurysm: Bioinformatics analysis. Front Cardiovasc Med. 9:9916132022. View Article : Google Scholar : PubMed/NCBI

Golledge J: Abdominal aortic aneurysm: Update on pathogenesis and medical treatments. Nat Rev Cardiol. 16:225–242. 2019. View Article : Google Scholar

Quintana RA and Taylor WR: Cellular Mechanisms of Aortic Aneurysm Formation. Circ Res. 124:607–618. 2019. View Article : Google Scholar : PubMed/NCBI

Sampilvanjil A, Karasawa T, Yamada N, Komada T, Higashi T, Baatarjav C, Watanabe S, Kamata R, Ohno N and Takahashi M: Cigarette smoke extract induces ferroptosis in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 318:H508–H518. 2020. View Article : Google Scholar : PubMed/NCBI

Chen L, Liu Y, Wang Z, Zhang L, Xu Y, Li Y, Zhang L, Wang G, Yang S and Xue G: Mesenchymal stem cell-derived extracellular vesicles protect against abdominal aortic aneurysm formation by inhibiting NET-induced ferroptosis. Exp Mol Med. 55:939–951. 2023. View Article : Google Scholar : PubMed/NCBI

Zhuang J, Zhu H, Cheng Z, Hu X, Yu X, Li J, Liu H, Tang P, Zhang Y, Xiong X and Deng H: PCSK9, a novel immune and ferroptosis related gene in abdominal aortic aneurysm neck. Sci Rep. 13:60542023. View Article : Google Scholar : PubMed/NCBI

Li N, Yi X, He Y, Huo B, Chen Y, Zhang Z, Wang Q, Li Y, Zhong X, Li R, et al: Targeting ferroptosis as a novel approach to alleviate aortic dissection. Int J Biol. 18:4118–4134. 2022. View Article : Google Scholar

Shi H, Wei J and He C: Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers. Mol Cell. 74:640–650. 2019. View Article : Google Scholar : PubMed/NCBI

Chen Y, Yi X, Huo B, He Y, Guo X, Zhang Z, Zhong X, Feng X, Fang ZM, Zhu XH, et al: BRD4770 functions as a novel ferroptosis inhibitor to protect against aortic dissection. Pharmacol Res. 177:1061222022. View Article : Google Scholar : PubMed/NCBI

Kobashigawa J, Zuckermann A, Macdonald P, Leprince P, Esmailian F, Luu M, Mancini D, Patel J, Razi R, Reichenspurner H, et al: Report from a consensus conference on primary graft dysfunction after cardiac transplantation. J Heart Lung Transplant. 33:327–340. 2014. View Article : Google Scholar : PubMed/NCBI

Lund LH, Edwards LB, Kucheryavaya AY, Dipchand AI, Benden C, Christie JD, Dobbels F, Kirk R, Rahmel AO, Yusen RD, et al: The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report-2013; Focus Theme: Age. J Heart Lung Transplant. 32:951–964. 2013. View Article : Google Scholar : PubMed/NCBI

Bai T, Li M, Liu Y, Qiao Z and Wang Z: Inhibition of ferroptosis alleviates atherosclerosis through attenuating lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cell. Free Radic Biol Med. 160:92–102. 2020. View Article : Google Scholar : PubMed/NCBI

Neufeld EJ: Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: New data, new questions. Blood. 107:3436–3441. 2006. View Article : Google Scholar : PubMed/NCBI

Philipp S, Cui L, Ludolph B, Kelm M, Schulz R, Cohen MV and Downey JM: Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS. Am J Physiol Heart Circ Physiol. 290:H450–H457. 2006. View Article : Google Scholar

Duffy SJ, Biegelsen ES, Holbrook M, Russell JD, Gokce N, Keaney JF Jr and Vita JA: Iron chelation improves endothelial function in patients with coronary artery disease. Circulation. 103:2799–2804. 2001. View Article : Google Scholar : PubMed/NCBI

Wong CAC and Leitch HA: Delayed time from RBC transfusion dependence to first cardiac event in lower IPSS risk MDS patients receiving iron chelation therapy. Leuk Res. 83:1061702019. View Article : Google Scholar : PubMed/NCBI

Paraskevaidis IA, Iliodromitis EK, Vlahakos D, Tsiapras DP, Nikolaidis A, Marathias A, Michalis A and Kremastinos DT: Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: Immediate and long-term significance. Eur Heart J. 26:263–270. 2005. View Article : Google Scholar

Tadokoro T, Ikeda M, Ide T, Deguchi H, Ikeda S, Okabe K, Ishikita A, Matsushima S, Koumura T, Yamada KI, et al: Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight. 5:e1327472020. View Article : Google Scholar : PubMed/NCBI

Zilka O, Shah R, Li B, Friedmann Angeli JP, Griesser M, Conrad M and Pratt DA: On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent Sci. 3:232–243. 2017. View Article : Google Scholar : PubMed/NCBI

Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS and Stockwell BR: Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci USA. 113:E4966–E4975. 2016. View Article : Google Scholar : PubMed/NCBI

Watanabe Y and Tatsuno I: Prevention of cardiovascular events with omega-3 polyunsaturated fatty acids and the mechanism involved. J Atheroscler Thromb. 27:183–198. 2020. View Article : Google Scholar :

Bibli SI, Hu J, Leisegang MS, Wittig J, Zukunft S, Kapasakalidi A, Fisslthaler B, Tsilimigras D, Zografos G, Filis K, et al: Shear stress regulates cystathionine γ lyase expression to preserve endothelial redox balance and reduce membrane lipid peroxidation. Redox Biol. 28:1013792020. View Article : Google Scholar

Chakraborty A, Li Y, Zhang C, Li Y, LeMaire SA and Shen YH: Simvastatin Ameliorates Diabetic Cardiomyopathy by Attenuating Oxidative Stress and Inflammation in Rats. Progress in Cardiovascular Diseases. 84:113–117. 1990.

Bai YT, Chang R, Wang H, Xiao FJ, Ge RL and Wang LS: ENPP2 protects cardiomyocytes from erastin-induced ferroptosis. Biochem Biophys Res Commun. 499:44–51. 2018. View Article : Google Scholar : PubMed/NCBI

Prasad A, Andrews NP, Padder FA, Husain M and Quyyumi AA: Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability. J Am Coll Cardiol. 34:507–514. 1999. View Article : Google Scholar : PubMed/NCBI

Imai H, Matsuoka M, Kumagai T, Sakamoto T and Koumura T: Lipid peroxidation-dependent cell death regulated by GPx4 and ferroptosis. Curr Top Microbiol Immunol. 403:143–170. 2017.PubMed/NCBI

Hinman A, Holst CR, Latham JC, Bruegger JJ, Ulas G, McCusker KP, Amagata A, Davis D, Hoff KG, Kahn-Kirby AH, et al: Vitamin E hydroquinone is an endogenous regulator of ferroptosis via redox control of 15-lipoxygenase. PLoS One. 13:e02013692018. View Article : Google Scholar : PubMed/NCBI

Upston JM, Kritharides L and Stocker R: The role of vitamin E in atherosclerosis. Prog Lipid Res. 42:405–422. 2003. View Article : Google Scholar : PubMed/NCBI

Steinberg D: Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis? Curr Opin Lipidol. 11:603–607. 2000. View Article : Google Scholar : PubMed/NCBI

Cogny A, Paul JL, Soni T, Atger V and Moatti N: Vitamin E: Metabolism and role in atherosclerosis. Ann Biol Clin (Paris). 52:515–522. 1994.

Dludla PV, Dias SC, Obonye N, Johnson R, Louw J and Nkambule BB: A Systematic Review on the Protective Effect of N-Acetyl Cysteine Against Diabetes-Associated Cardiovascular Complications. Am J Cardiovasc Drugs. 18:283–298. 2018. View Article : Google Scholar : PubMed/NCBI

Bartekova M, Barancik M, Ferenczyova K and Dhalla NS: Beneficial Effects of N-acetylcysteine and N-mercaptopropionylglycine on ischemia reperfusion injury in the heart. Curr Med Chem. 25:355–366. 2018. View Article : Google Scholar

Badgley MA, Kremer DM, Maurer HC, DelGiorno KE, Lee HJ, Purohit V, Sagalovskiy IR, Ma A, Kapilian J, Firl CEM, et al: Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science. 368:85–89. 2020. View Article : Google Scholar : PubMed/NCBI

Wang C, Zhu L, Yuan W, Sun L, Xia Z, Zhang Z and Yao W: Diabetes aggravates myocardial ischaemia reperfusion injury via activating Nox2-related programmed cell death in an AMPK-dependent manner. J Cell Mol Med. 24:6670–6679. 2020. View Article : Google Scholar : PubMed/NCBI

Xiao Z, Kong B, Fang J, Qin T, Dai C, Shuai W and Huang H: Ferrostatin-1 alleviates lipopolysaccharide-induced cardiac dysfunction. Bioengineered. 12:9367–9376. 2021. View Article : Google Scholar : PubMed/NCBI

Feng Y, Madungwe NB, Imam Aliagan AD, Tombo N and Bopassa JC: Liproxstatin-1 protects the mouse myocardium against ischemia/reperfusion injury by decreasing VDAC1 levels and restoring GPX4 levels. Biochem Biophys Res Commun. 520:606–611. 2019. View Article : Google Scholar : PubMed/NCBI

Fang X, Wang H and Han D: Traditional Chinese medicine for cardiovascular disease. Proc Natl Acad Sci USA. 12:9367–9376. 2021.

Li W, Feng G and Gauthier JM: Translating traditional herbal formulas into modern drugs: a network-based analysis of Xiaoyao decoction. Cell Death Differ. 119:1183562020.

Ferrara PE, Codazza S, Cerulli S, Maccauro G, Ferriero G and Ronconi G: Physical modalities for the conservative treatment of wrist and hand's tenosynovitis: A systematic review. Semin Arthritis Rheum. 50:1280–1290. 2020. View Article : Google Scholar : PubMed/NCBI

Wang R, Wang M, Zhou J, Wu D, Ye J, Sun G and Sun X: Saponins in Chinese Herbal Medicine Exerts Protection in Myocardial Ischemia-Reperfusion Injury: Possible mechanism and target analysis. Front Pharmacol. 11:5708672021. View Article : Google Scholar : PubMed/NCBI

Chen GQ, Benthani FA, Wu J, Liang D, Bian ZX and Jiang X: Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis. Cell Death Differ. 27:242–254. 2020. View Article : Google Scholar :

Wang S, Liu W, Wang J and Bai X: Curculigoside inhibits ferroptosis in ulcerative colitis through the induction of GPX4. Life Sci. 259:1183562020. View Article : Google Scholar : PubMed/NCBI

Zhu K, Zhu X, Liu S, Yu J, Wu S and Hei M: Glycyrrhizin attenuates hypoxic-ischemic brain damage by inhibiting ferroptosis and neuroinflammation in neonatal rats via the HMGB1/GPX4 Pathway. Oxid Med Cell Longev. 2022:84385282022. View Article : Google Scholar : PubMed/NCBI

Fan Z, Cai L, Wang S, Wang J and Chen B: Baicalin prevents myocardial ischemia/reperfusion injury through inhibiting ACSL4 mediated ferroptosis. Front Pharmacol. 12:6289882021. View Article : Google Scholar : PubMed/NCBI

Zeng X, Li J and Li Z: Ginsenoside Rd mitigates myocardial ischemia-reperfusion injury via Nrf2/HO-1 signaling pathway. Int J Clin Exp Med. 8:14497–14504. 2015.PubMed/NCBI

Wang D, Chen T and Liu F: Betulinic acid alleviates myocardial hypoxia/reoxygenation injury via inducing Nrf2/HO-1 and inhibiting p38 and JNK pathways. Eur J Pharmacol. 838:53–59. 2018. View Article : Google Scholar : PubMed/NCBI

Li T, Tan Y, Ouyang S, He J and Liu L: Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis. Gene. 808:1459682022. View Article : Google Scholar

Cao H, Wang P, Li N, Liu D, Ma J, Fan R and Zhou Z: Practice of Comparative Effectiveness Research to Identify Treatment Characteristics of Similar Chinese Patent Medicine for Angina Pectoris. Evid Based Complement Alternat Med. 2017:70627142017. View Article : Google Scholar : PubMed/NCBI

Wu L, Fan Z, Gu L, Liu J, Cui Z, Yu B, Kou J and Li F: QiShenYiQi dripping pill alleviates myocardial ischemia-induced ferroptosis via improving mitochondrial dynamical homeostasis and biogenesis. J Ethnopharmacol. 308:1162822023. View Article : Google Scholar : PubMed/NCBI

Xu S, Wu B, Zhong B, Lin L, Ding Y, Jin X, Huang Z, Lin M, Wu H and Xu D: Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2)/System xc-/glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis. Bioengineered. 12:10924–10934. 2021. View Article : Google Scholar : PubMed/NCBI

Zhao L, Shi H, Zhang F, Xue H and Han Q: Hederagenin protects against myocardial ischemia-reperfusion injury via attenuating ALOX5-mediated ferroptosis. Naunyn-Schmiedeberg's Arch Pharmacol. 397:3411–3424. 2024. View Article : Google Scholar

D'Onofrio N, Servillo L and Balestrieri ML: SIRT1 and SIRT6 signaling pathways in cardiovascular disease protection. Antioxid Redox Signal. 28:711–732. 2018. View Article : Google Scholar :

Kane AE and Sinclair DA: Sirtuins and NAD(⁺)in the development and treatment of metabolic and cardiovascular diseases. Circ Res. 123:868–885. 2018. View Article : Google Scholar : PubMed/NCBI

Li D, Liu X, Pi W, Zhang Y, Yu L, Xu C, Sun Z and Jiang J: Fisetin Attenuates doxorubicin-induced cardiomyopathy in vivo and in vitro by inhibiting ferroptosis through SIRT1/Nrf2 signaling pathway activation. Front Pharmacol. 12:8084802022. View Article : Google Scholar : PubMed/NCBI

Wu S, Zhu J, Wu G, Hu Z, Ying P, Bao Z, Ding Z and Tan X: 6-Gingerol alleviates ferroptosis and inflammation of diabetic cardiomyopathy via the Nrf2/HO-1 pathway. Oxid Med Cell Longev. Dec 31–2022.Epub ahead of print. View Article : Google Scholar

Zhou YX, Zhang H and Peng C: Puerarin: A Review of Pharmacological Effects. Phytother Res. 28:961–975. 2014. View Article : Google Scholar

Liu B, Zhao C, Li H, Chen X, Ding Y and Xu S: Puerarin protects against heart failure induced by pressure overload through mitigation of ferroptosis. Biochem Biophys Res Commun. 497:233–240. 2018. View Article : Google Scholar : PubMed/NCBI

Zhang D, Zhang Y, Gao Y, Chai X, Pi R, Chan G and Hu Y: Current understanding of iron homeostasis. Gene. 106:1559S–1566S. 2017.

Fang X, An P, Wang H, Wang X, Shen X, Li X, Min J, Liu S and Wang F: Dietary intake of heme iron and risk of cardiovascular disease: A dose-response meta-analysis of prospective cohort studies. Nutr Metab Cardiovasc Dis. 25:24–35. 2015. View Article : Google Scholar

Han M, Guan L and Ren Y: Physical modalities for the conservative treatment of wrist and hand's tenosynovitis: A systematic review. Asia Pac J Clin Nutr. 29:309–321. 2020.

Zhao L, Shi H and Zhang F: Deficiency in Beclin1 attenuates alcohol-induced cardiac dysfunction via inhibition of ferroptosis. Front Pharmacol. 2021:1–15. 2021.

Bao X, Luo X, Bai X, Lv Y, Weng X, Zhang S, Leng Y, Huang J, Dai X, Wang Y, et al: Cigarette tar mediates macrophage ferroptosis in atherosclerosis through the hepcidin/FPN/SLC7A11 signaling pathway. Free Radic Biol Med. 201:76–88. 2023. View Article : Google Scholar : PubMed/NCBI

Violi F, Nocella C, Loffredo L, Carnevale R and Pignatelli P: Interventional study with vitamin E in cardiovascular disease and meta-analysis. Free Radic Biol Med. 178:26–41. 2022. View Article : Google Scholar

Tang LJ, Zhou YJ, Xiong XM, Li NS, Zhang JJ, Luo XJ and Peng J: Ubiquitin-specific protease 7 promotes ferroptosis via activation of the p53/TfR1 pathway in the rat hearts after ischemia/reperfusion. Free Radic Biol Med. 162:339–352. 2021. View Article : Google Scholar

Wang C, Yuan W, Hu A, Lin J, Xia Z, Yang CF, Li Y and Zhang Z: Dexmedetomidine alleviated sepsis-induced myocardial ferroptosis and septic heart injury. Mol Med Rep. 22:175–184. 2020. View Article : Google Scholar : PubMed/NCBI

Ning D, Yang X, Wang T, Jiang Q, Yu J and Wang D: Atorvastatin treatment ameliorates cardiac function and remodeling induced by isoproterenol attack through mitigation of ferroptosis. Biochem Biophys Res Commun. 574:39–47. 2021. View Article : Google Scholar : PubMed/NCBI

Mishima E, Sato E, Ito J, Yamada KI, Suzuki C, Oikawa Y, Matsuhashi T, Kikuchi K, Toyohara T, Suzuki T, et al: Drugs repurposed as antiferroptosis agents suppress organ damage, including AKI, by functioning as lipid peroxyl radical scavengers. J Am Soc Nephrol. 31:280–296. 2020. View Article : Google Scholar :

Conlon M, Poltorack CD, Forcina GC, Armenta DA, Mallais M, Perez MA, Wells A, Kahanu A, Magtanong L, Watts JL, et al: A compendium of kinetic modulatory profiles identifies ferroptosis regulators. Nat Chem Biol. 17:665–674. 2021. View Article : Google Scholar : PubMed/NCBI

Oettl K, Greilberger J, Zangger K, Haslinger E, Reibnegger G and Jürgens G: Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity. Biochem Pharmacol. 62:241–248. 2001. View Article : Google Scholar : PubMed/NCBI

Hong M, Rong J, Tao X and Xu Y: The emerging role of ferroptosis in cardiovascular diseases. Front Pharmacol. 13:8220832022. View Article : Google Scholar : PubMed/NCBI

Fang W, Xie S and Deng W: Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future. Cell Biol Toxicol. 40:172024. View Article : Google Scholar : PubMed/NCBI